Galapagos to work on arthritis drug
Galapagos to work on arthritis drug
BRUSSELS: Belgian-Dutch biotechnology firm Galapagos said on Wednesday it would work with two Dutch companies and a university to develop drugs to treat arthritis. Galapagos said it had formed a two-year partnership with ZoBio, Pyxis Discovery and Leiden University to start a small molecular research programme in the area of arthritis.
“It fits within our strategy to create a broad pipeline of candidate drugs against bone and joint diseases,” it said in a statement.
The programme will be partly funded by the Dutch government, it said.